LNK754 (Synonyms: (Rac)-LNK-754; (Rac)-OSI-754) |
| Catalog No.GC31242 |
LNK754 est le racémate de CP-609754.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 439153-64-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
LNK754 is a farnesyltransferase inhibitor, used for the treatment of cancer and Alzheimer's disease.
LNK-754 (0.9 mg/kg) significantly reduces α-synuclein plaques in a mouse model of PD, APP(SL), at 6 months of age for 3 months[1].
[1]. Keith T Gagnon. HD Therapeutics-CHDI Fifth Annual Conference. IDrugs. 2010 Apr;13(4):219-23.
Review for LNK754
Average Rating: 5 (Based on Reviews and 29 reference(s) in Google Scholar.)
Review for LNK754
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *